Literature DB >> 24425103

Downregulated expression of metastasis associated in colon cancer 1 (MACC1) reduces gallbladder cancer cell proliferation and invasion.

Yong Wang1, Qiang Hong, Jianjun Wang, Yuejun Fang, Conggang Hu.   

Abstract

Metastasis associated in colon cancer 1 (MACC1), a key regulator of the hepatocyte growth factor (HGF)/MET signaling pathway, has been implicated in multiple human cancers. However, little is known regarding its expression and biological function in human gallbladder cancer (GBC). In this study, we focused on the clinical significance and biological functions of MACC1 in GBC and found that MACC1 protein overexpression was frequently detected in GBC tissues. Patients with MACC1-positive tumors had worse overall survival than patients with MACC1-negative tumors. Furthermore, treatment of GBC lines with MACC1-targeting small interfering RNA oligonucleotides (MACC1-siRNA) significantly reduced the proliferation of GBC-SD and OCUG-1 cell lines and diminished both anchorage-independent growth on soft agar and cell migration. These data indicate that MACC1 acts as a putative oncogene in GBC and could be a novel diagnostic and therapeutic target for GBC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24425103     DOI: 10.1007/s13277-013-1499-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

1.  Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence.

Authors:  Hidehiko Shimokawa; Hidetaka Uramoto; Takamitsu Onitsuka; Gu Chundong; Takeshi Hanagiri; Tsunehiro Oyama; Kosei Yasumoto
Journal:  J Thorac Cardiovasc Surg       Date:  2010-11-19       Impact factor: 5.209

2.  MACC1 controls Met: what a difference an Sp1 site makes.

Authors:  Ulrike Stein; Janice Smith; Wolfgang Walther; Franziska Arlt
Journal:  Cell Cycle       Date:  2009-08-13       Impact factor: 4.534

3.  Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer.

Authors:  Manisha Juneja; Katharina Ilm; Peter M Schlag; Ulrike Stein
Journal:  Mol Oncol       Date:  2013-06-06       Impact factor: 6.603

4.  MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer.

Authors:  Cristina Migliore; Valentina Martin; Vera P Leoni; Angelo Restivo; Luigi Atzori; Annalisa Petrelli; Claudio Isella; Luigi Zorcolo; Ivana Sarotto; Giuseppe Casula; Paolo M Comoglio; Amedeo Columbano; Silvia Giordano
Journal:  Clin Cancer Res       Date:  2011-12-16       Impact factor: 12.531

5.  Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion.

Authors:  Lin Wang; Yajun Wu; Li Lin; Pengmin Liu; Hui Huang; Wenjun Liao; Dayong Zheng; Qiang Zuo; Li Sun; Na Huang; Min Shi; Yulin Liao; Wangjun Liao
Journal:  Int J Cancer       Date:  2013-03-29       Impact factor: 7.396

6.  MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.

Authors:  Ulrike Stein; Wolfgang Walther; Franziska Arlt; Holger Schwabe; Janice Smith; Iduna Fichtner; Walter Birchmeier; Peter M Schlag
Journal:  Nat Med       Date:  2008-12-21       Impact factor: 53.440

7.  Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma.

Authors:  Xiang-Song Wu; Liu-Bin Shi; Mao-Lan Li; Qian Ding; Hao Weng; Wen-Guang Wu; Yang Cao; Run-Fa Bao; Yi-Jun Shu; Qi-Chen Ding; Jia-Sheng Mu; Jun Gu; Ping Dong; Ying-Bin Liu
Journal:  Ann Surg Oncol       Date:  2013-10-01       Impact factor: 5.344

8.  Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas.

Authors:  Céline Pinheiro; Adhemar Longatto-Filho; Cristovam Scapulatempo; Luísa Ferreira; Sandra Martins; Luc Pellerin; Mesquita Rodrigues; Venancio A F Alves; Fernando Schmitt; Fátima Baltazar
Journal:  Virchows Arch       Date:  2008-01-10       Impact factor: 4.064

9.  Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis.

Authors:  Ulrike Stein; Susen Burock; Pia Herrmann; Ina Wendler; Markus Niederstrasser; Klaus-Dieter Wernecke; Peter M Schlag
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway.

Authors:  Fengjiao Meng; Hui Li; Huijuan Shi; Qingxu Yang; Fenfen Zhang; Yang Yang; Lili Kang; Tiantian Zhen; Sujuan Dai; Yu Dong; Anjia Han
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more
  7 in total

1.  MACC1 overexpression and survival in solid tumors: a meta-analysis.

Authors:  Gang Wang; Zhixuan Fu; Dechuan Li
Journal:  Tumour Biol       Date:  2014-10-19

2.  Prognostic Impact of Modulators of G proteins in Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer.

Authors:  Jorge Barbazan; Ying Dunkel; Hongying Li; Ulrich Nitsche; Klaus-Peter Janssen; Karen Messer; Pradipta Ghosh
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

3.  Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer.

Authors:  He Li; Yi-Xin Chen; Jia-Gen Wen; Hong-Hao Zhou
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

4.  LncRNA FGD5-AS1 Facilitates the Radioresistance of Breast Cancer Cells by Enhancing MACC1 Expression Through Competitively Sponging miR-497-5p.

Authors:  Ji Li; Changjiang Lei; Bineng Chen; Qingfang Zhu
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

Review 5.  The potential therapeutic applications and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) in cancers.

Authors:  Ewa Katarzyna Kopczyńska
Journal:  Contemp Oncol (Pozn)       Date:  2016-09-05

6.  Mir-338-3p Inhibits Malignant Biological Behaviors of Glioma Cells by Targeting MACC1 Gene.

Authors:  Chao Shang; Yang Hong; Yan Guo; Yi-xue Xue
Journal:  Med Sci Monit       Date:  2016-03-03

7.  Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1.

Authors:  Manisha Juneja; Dennis Kobelt; Wolfgang Walther; Cynthia Voss; Janice Smith; Edgar Specker; Martin Neuenschwander; Björn-Oliver Gohlke; Mathias Dahlmann; Silke Radetzki; Robert Preissner; Jens Peter von Kries; Peter Michael Schlag; Ulrike Stein
Journal:  PLoS Biol       Date:  2017-06-01       Impact factor: 8.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.